Related references
Note: Only part of the references are listed.Islet Microenvironment, Modulated by Vascular Endothelial Growth Factor-A Signaling, Promotes β Cell Regeneration
Marcela Brissova et al.
CELL METABOLISM (2014)
A review of the profile of endothelin axis in cancer and its management
Soussan Irani et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Endothelin 1 in cancer: biological implications and therapeutic opportunities
Laura Rosano et al.
NATURE REVIEWS CANCER (2013)
An Antibody-Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma
Jyoti Asundi et al.
CLINICAL CANCER RESEARCH (2011)
Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells
Mayra Paolillo et al.
PHARMACOLOGICAL RESEARCH (2010)
Synergistic Growth Inhibitory Effects of the Dual Endothelin-1 Receptor Antagonist Bosentan on Pancreatic Stellate and Cancer Cells
Brit Fitzner et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study):: a double-blind, randomised controlled trial
N. Galie et al.
LANCET (2008)
Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer
P Wülfing et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
